Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Pcp51 - Observational Studies Collecting Patient Preferences and Experiences: Regulatory Differences Across Countries in Europe

Value in Health

English

Php277 - How Do Bellwether Hta Agencies Evaluate Biosimilars?

English

Pin93 - Real-World Tigecycline Use in China for the Treatment of Complicated Intra-Abdominal Infections (Ciais)

English

Pnd4 - Clobazam as Intermitent Prophylaxis in Typical Febrile Seizures and Their Anemic Status

English

Prm6 - Increased Risk of Cutaneous Adverse Drug Reaction Among Older Adults Exposed to Polypharmacy

English

Pcp43 - Health Impact Modelling (Him): Concept, Approach and Real-World Data Needs for the Estimation of Potential Effectiveness Provided by a Pharma Company Portfolio

English

Different Values in Cost-Effectiveness Research: Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)

English

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

English

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

English

Pmd79 - Cost-Effectiveness of Ultrasound-Guided Central Venous Catheterisation From the German Payer Perspective.

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Pcp51 - Observational Studies Collecting Patient Preferences and Experiences: Regulatory Differences Across Countries in Europe

Php277 - How Do Bellwether Hta Agencies Evaluate Biosimilars?

Pin93 - Real-World Tigecycline Use in China for the Treatment of Complicated Intra-Abdominal Infections (Ciais)

Pnd4 - Clobazam as Intermitent Prophylaxis in Typical Febrile Seizures and Their Anemic Status

Prm6 - Increased Risk of Cutaneous Adverse Drug Reaction Among Older Adults Exposed to Polypharmacy

Pcp43 - Health Impact Modelling (Him): Concept, Approach and Real-World Data Needs for the Estimation of Potential Effectiveness Provided by a Pharma Company Portfolio

Different Values in Cost-Effectiveness Research: Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Pmd79 - Cost-Effectiveness of Ultrasound-Guided Central Venous Catheterisation From the German Payer Perspective.